January 21st 2016

MAPPs newsletter NEW HEADER

E-NEWSLETTER June 2016
littlesq
In this newsletter, Dr Sarah Garner of NICE writes on her experiences speaking at the EMIF conference in Budapest, and her impressions regarding the rapid changes in science and technology since her last visit to Budapest more than 10 years ago. As the keynote speaker in the EMIF Conferences, E-managing the Future of Health Data, Garner spoke on a number of initiatives making use of real world evidence, specifically highlighting the significance of RWE in furthering the conversation on MAPPs.  

Additionally, Luk Maes, Executive Director Scientific Policies Europe, Bristol-Myers Squibb, Belgium, writes about his experience co-chairing the panel "MAPPs: The IMI ADAPT SMART Project" at the DIA EuroMeeting 2016. Here, Maes provides some key takeaways from the panel, which included participation from payers, consumers, and HTA bodies.

Both Garner and Maes make one thing clear: The science and technology that makes MAPPs possible is there, but it's up to the scientific and healthcare communities to harness this potential. 
littlesq
Editorial
littlesq  
Sarah Garner-300x300

"Advances in science and technology are there—It’s up to us to keep up with them": An Editorial From Sarah Garner of NICE

As the keynote speaker in the EMIF Conferences, E-managing the Future of Health Data, Dr Sarah Garner spoke on a number of initiatives making use of real world evidence—specifically highlighting the significance in RWE in furthering the conversation on MAPPs. Here, she reflects on how the opportunities changes in technology allow us today and how initiatives like ADAPT SMART are paving the way for MAPPs.

READ THE FULL EDITORIAL...

 
 
 
Panel Review
littlesq littlesq
LukMaes-1

 
Luk Maes Reports on DIA Hamburg's "MAPPs: The IMI ADAPT SMART Project" - Views from Payers, Consumers, and HTA Bodies

This April, thought leaders in the field of adaptive pathways met at the DIA EuroMeeting 2016 in Hamburg to discuss the progress made in MAPPs (“Medicines Adaptive Pathways to Patients”) —as well as the challenges still ahead. Co-chairing the panel “MAPPs: The IMI ADAPT SMART Project” was Luk Maes, Executive Director Scientific Policies Europe, Bristol-Myers Squibb, Belgium. He was joined as co-chair of the panel by Hans-Georg Eichler, Senior Medical Officer, European Medicines Agency, UK. Here, Luk Maes provides some key takeaways from the panel.

READ THE FULL OVERVIEW...

 
 
EFPIA Brussels Office
littlesq littlesq
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: anna.szczepanska@efpia.eu or science-policy@efpia.eu 
littlesq

footer

littlesq
 

 

SaveSave




Click to view this email in a browser

If you no longer wish to receive these emails, please reply to this message with "Unsubscribe" in the subject line or simply click on the following link: Unsubscribe

Vital Transformation
107 Leopold III Laan
Wezembeek-Oppem, 1970
Belgium

Read the VerticalResponse marketing policy.

Try Email Marketing with VerticalResponse!